Currently out of the existing stock ratings of Eric Serotta, 18 are a BUY (28.57%), 8 are a SELL (12.7%), 37 are a HOLD (58.73%).

Eric Serotta

Work Performance Price Targets & Ratings Chart

Analyst Eric Serotta, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 80.71% that have a potential upside of 14.99% achieved within 81 days.

Eric Serotta’s has documented 132 price targets and ratings displayed on 6 stocks. The coverage is on the Consumer Defensive sector.

Most recent stock forecast was given on CELH, Celsius Holdings at 07-Aug-2026.

Wall Street Analyst Eric Serotta

Analyst best performing recommendations are on COCO (VITA COCO COMPANY).
The best stock recommendation documented was for COCO (VITA COCO COMPANY) at 7/28/2026. The price target of $68 was fulfilled within 1 day with a profit of $1.58 (2.27%) receiving and performance score of 22.71.

Average potential price target upside

SAM Boston Beer Company CELH Celsius Holdings MO Altria Group COCO Vita Coco Company PM Philip Morris International FRPT Freshpet

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 30-May-2023

$295

$109.23 (58.80%)

$349

Hold Since 22-Jul-2022

$210

$24.23 (13.04%)

$242

Hold Since 17-Dec-2025

$185

$-0.77 (-0.41%)

$195

Hold Since 21-Jun-2022

$190

$4.23 (2.28%)

$250

Sell Since 28-Jul-2023

$169

$-16.77 (-9.03%)

$187

Show more analysts

Please expand the browser size to see the chart

Which stock is Eric Serotta is most bullish on?

Potential upside of $34.23 has been obtained for SAM (BOSTON BEER COMPANY)

Which stock is Eric Serotta is most reserved on?

Potential downside of -$0.76 has been obtained for FRPT (FRESHPET)

What Year was the first public recommendation made by Eric Serotta?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?